Formula Growth’s Evolus EOLS Stock Holding History

Formula Growth’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-90,830	Closed	-$1M	–	126
2024 Q4	$1M	Sell	90,830 -47,170	-34%	-$663K	0.34%	95
2024 Q3	$2.24M	Buy	+138,000	New	+$1.93M	0.77%	52

Other funds holding EOLS

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Formula Growth's EOLS Position: Q1 2025 in Review

Formula Growth sold out of Evolus (EOLS) in Q1 2025, closing a stake of 90,830 shares — an estimated $1M sold.

Formula Growth first reported a position in EOLS in Q3 2024 and held it in 2 quarters. The position peaked at $2.24M in Q3 2024. 179 funds tracked by Wall St. Rank hold EOLS as of Q1 2025.

Formula Growth reported no remaining Evolus position as of Q1 2025 after selling out during the quarter.
Formula Growth sold 90,830 Evolus shares in Q1 2025, an estimated $1M.
Formula Growth first reported a position in Evolus in Q3 2024 and held it in 2 quarters.
Formula Growth's Evolus position peaked at $2.24M in Q3 2024.
179 funds tracked by Wall St. Rank held Evolus as of Q1 2025.

Based on Formula Growth's 13F filing for Q1 2025, filed 14 May 2025.